Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › CTNM

SILVERARC CAPITAL MANAGEMENT, LLC position in CTNM

CONTINEUM THERAPEUTICS INC CL A · Health Care

SILVERARC CAPITAL MANAGEMENT, LLC reported holding 296,135 shares of CTNM (CONTINEUM THERAPEUTICS INC CL A) in its Q2 2026 13F filing — a position valued at US$4.9M, representing 0.57% of its reported portfolio and ranking #47 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed CTNM holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)296.13K sh
Reported value held$4.85M
Portfolio Weight0.57%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SILVERARC CAPITAL MANAGEMENT, LLC's CTNM position evolved

SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in CTNM in Q3 2025 at 166,161 shares (US$2.0M). The position peaked in Q2 2026 at 296,135 shares, worth US$4.9M. Across 4 filings, SILVERARC CAPITAL MANAGEMENT, LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 296,135 shares valued at US$4.9M — a reduction of -5,594 shares quarter over quarter.. Notable position changes include a 85% increase in Q4 2025 (shares rose 14% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 166.16K $1.95M New
Q4 2025 307.54K $3.52M Add
Q1 2026 301.73K $3.94M Reduce
Q2 2026 296.13K $4.85M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CTNM and 13F data

CTNM (CONTINEUM THERAPEUTICS INC CL A) is a Health Care company. 63 other funds we track also report a position in CTNM — the largest reported positions include MONTANOVA CAPITAL, LLC (US$46.6M), JOHNSON & JOHNSON (US$32.4M), GREAT POINT PARTNERS LLC (US$15.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CTNM

All CTNM fund holders →

FAQ

How long has SILVERARC CAPITAL MANAGEMENT, LLC held CTNM?

SILVERARC CAPITAL MANAGEMENT, LLC has disclosed CTNM holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in CTNM?

As of Q2 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 296.13K shares of CTNM (CONTINEUM THERAPEUTICS INC CL A), valued at $4.85M, representing 0.57% of its reported portfolio and ranking #47.

Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling CTNM?

In the latest 13F filing (Q2 2026), SILVERARC CAPITAL MANAGEMENT, LLC reduced its position in CTNM. The position peaked in Q2 2026 at 296.13K shares.

Which other funds hold CTNM?

Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, GREAT POINT PARTNERS LLC, among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.